On 7th September 2021, Johnson & Johnson Innovation, in collaboration with Janssen Research & Development, LLC’s Oncology Therapeutic Area, will host a virtual scientific and strategic partnering event on state-of-the-art developments in immune cell engagers in hematological malignancies, bringing together entrepreneurs, start-ups, researchers, and scientists from across Europe and beyond.

We are seeking to connect with entrepreneurs, biotechs and academic researchers who aspire to these scientific strategies for a discussion on the next wave of science and innovation in immune engagers. We also want to explore how Johnson & Johnson Innovation could collaborate with the aim to support opportunities and enable innovators and their innovations to reach full therapeutic potential for patients.

  • September 7, 2021 @ 3:00 pm
  • September 7, 2021
  • Switzerland
Event starts in
  • 00

  • 00

  • 00


Basel, Switzerland

Contact Form